Muhammad Bilal Abid^1*, Noel Estrada-Merly, MS^1*, Mei-Jie Zhang, PhD^1,2*, Karen Chen, MS^1*, Christopher Bredeson, MD, MSc, FRCPC^3*, David S. Allan, MD, FRCPC, MSc³, Mitchell Sabloff, MSc, MD, FRCPC³, Mark R. Litzow, MD⁴, Partow Kebriaei, MD⁵ and Wael Saber, MD, MS^1*

¹CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
²Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI
³Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada
⁴Division of Hematology, Mayo Clinic, Rochester, MN
⁵Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Caner Saygin, MD¹, Gregory W. Roloff, MD², Christopher N Hahn, PhD³, Rakchha Chhetri, MBBS MHID Grad Cert. Biostat.^4*, Saar Gill, MD, PhD⁵, Hany Elmariah, MD, MS⁶, Chetasi Talati, MD^7*, Emma Nunley^8*, Guimin Gao^9*, Aelin Kim^8*, Michael R. Bishop, MD¹⁰, Satyajit Kosuri, MD^1*, Soma Das^11*, Deepak Singhal, MBBS, MD, FRCPA, FRACP^12*, Parvathy Venugopal, PhD¹³, Claire Homan, PhD^13*, Anna Brown, PhD¹³, Hamish S Scott, PhD¹⁴, Devendra Hiwase, MD, MBBS, PhD, FRACP, FRCPA^3,4,15 and Lucy A. Godley, MD, PhD¹⁶

¹Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
²Section of Hematology/Oncology, The University of Chicago, Chicago, IL
³Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia
⁴Department of Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia
⁵Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁶Moffitt Cancer Center, Tampa, FL
⁷Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
⁸University of Chicago Section of Hematology/Oncology, Chicago, IL
⁹University of Chicago Department of Informatics and Biostatistics, Chicago, IL
¹⁰The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
¹¹Department of Human Genetics, The University of Chicago, Chicago, IL
¹²Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia
¹³Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia
¹⁴Adelaide Medical School, University of Adelaide, Adelaide, Australia
¹⁵Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia
¹⁶Department of Medicine, Section of Hematology-Oncology, The University of Chicago, Chicago, IL

Najla El Jurdi, MD^1*, Michael Martens, PhD^2*, Claudio G. Brunstein, MD, PhD³, Paul O'Donnell, MD⁴, Stephanie J. Lee, MD, MPH⁵, Anita D'Souza, MD, MS⁶, Brent Logan, PhD^7*, Sanghee Hong, MD⁸, Karam Sandhu⁹, Roman M Shapiro, MD¹⁰, Anurag K. Singh, MD¹¹, Mary M. Horowitz, MD¹² and Betty K. Hamilton, MD¹³

¹Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
²Medical College of Wisconsin, Milwaukee, WI
³Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
⁴Massachusetts General Hospital Cancer Center, Boston, MA
⁵Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
⁶Center for International Blood and Marrow Transplant Research, Department of Medicine, The Medical College of Wisconsin Inc., Milwaukee, WI
⁷Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI
⁸Duke University, Durham
⁹City of Hope, Duarte
¹⁰Department of Medical Oncology, Dana-Farber Cancer Institute, Jamaica Plain, MA
¹¹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
¹²Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
¹³Cleveland Clinic Foundation, Cleveland, OH

Mitja Nabergoj, MD^1*, Dirk-Jan Eikema^2*, Nienke Zinger^3*, Uwe Platzbecker, MD⁴, Katja Sockel, MD^5*, Jürgen Finke, MD, PhD⁶, Nicolaus Kröger, MD^7*, Edouard Forcade, MD, PhD⁸, Arnon Nagler, MD⁹, Arnold Ganser, MD^10*, Johanna Tischer, MD^11*, Annoek E.C. Broers, MD, PhD^12*, Jurgen Kuball, MD¹³, Keith Wilson^14*, Hunault-Berger Mathilde, MD, PhD^15*, Matthew P. Collin, MD, PhD¹⁶, Domenico Russo, MD¹⁷, Estefanía Pérez López^18*, Grzegorz Helbig, MD, PhD^19*, Alberto Mussetti^20*, Kavita Raj^21*, Christof Scheid²², Donal P. McLornan, MD, PhD^23*, Marie Robin, MD, PhD^24* and Ibrahim Yakoub-Agha, MD, PhD²⁵

¹Hôpital du Valais – Institut Central des Hôpitaux (ICH), Sion, Switzerland
²EBMT Statistical Unit, Leiden, Netherlands
³EBMT Leiden Study Unit, Leiden, Netherlands
⁴Medical Clinical and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
⁵Department of Medicine I, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
⁶Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
⁷University Medical Center Hamburg-Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany
⁸Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Hôpital Haut-Leveque, Bordeaux, France
⁹Hematology and Bone Marrow Transplant Unit, Chaim Sheba Medical Center, Tel Hashomer, Israel
¹⁰Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hanover, Germany
¹¹Department of Internal Medicine III, University Hospital of Munich, Campus Grosshadern, Munich, -, Germany
¹²Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
¹³Department of Hematology, UMC Utrecht, Utrecht, Netherlands
¹⁴University Hospital of Wales, Cardiff, United Kingdom
¹⁵department of hematology, CHU Angers, Angers, ML, France
¹⁶Northern Centre for Bone Marrow Transplantation, Newcastle Upon Tyne, UK, Newcastle Upon Tyne, United Kingdom
¹⁷Unit of Blood Diseases and Bone Marrow Transplantation, Department of Clinical and Experimental Sciences, ASST-Spedali Civili, University of Brescia, Brescia, Italy
¹⁸Hematology Department, Hospital Clínico Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain
¹⁹Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland
²⁰Department of Hematology, Hospital Duran i Reynals, Instituto Catalán de Oncología, L'Hospitalet De Llobregat, Barcelona, Spain
²¹University College London Hospitals NHS Trust, London, United Kingdom
²²Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany
²³Haematology Department, Guy's and St Thomas' NHS Trust, London, United Kingdom
²⁴Hopital Saint Louis, APHP, Université de Paris Cité, Paris, FRA
²⁵Centre Hospitalier Universitaire de Lille LIRIC, INSERM U1286, Université de Lille, LILLE, France

Oren Pasvolsky, MD^1,2,3*, Rima M. Saliba, PhD^3*, Uday R Popat, MD³, Amin M Alousi, MD³, Rohtesh S. Mehta, MD³, Jason Yeh, PharmD^4*, Gheath Alatrash, PhD, DO³, Adeel Masood^3*, Jeremy L. Ramdial, MD³, Gabriela Rondon, MD³, Partow Kebriaei, MD³, Richard E Champlin, MD³, Elizabeth J Shpall, MD³ and Betul Oran, MD, MS³

¹Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
²Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Tel Aviv, Israel
³Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Division of Pharmacy, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Nahid Rashid, MD^1,2, Albert Yeh, MD^1,2, Marco Mielcarek, MD^3,4, Masumi Ueda Oshima, MD^1,4, Elizabeth F Krakow, MD, MSc^2,5, Lynn E. Onstad, ScM^5*, Laura Connelly-Smith^1,2*, Phuong Vo^1,2 and Stephanie J. Lee, MD, MPH^2,5

¹Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
²Department of Medicine, University of Washington, Seattle, WA
³Adult Blood and Marrow Transplant Program, Fred Hutchinson Cancer Research Center, Seattle, WA
⁴Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA
⁵Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA

Eduard Schulz^1*, Filip Pirsl^1*, David Beshensky^1*, Noa G. Holtzman, MD¹, Seth M. Steinberg, PhD^2* and Steven Z Pavletic, MD, MS¹

¹Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
²Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD

Gil Fridberg, MD^1*, Odelia Amit, MD^1*, Chen Karni, RN^1*, Dina Tshernichovsy, RN^1*, David Shasha, MD^2*, Vanessa Rouach, MD^3*, David Verssano, MD^4*, Amir Bar-Shai, MD^5*, Gilad Wasserman, MD^6*, Ilan Goldberg, MD^7*, Irit Avivi, MD^1* and Ron Ram, MD¹

¹BMT Unit, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
²Infectious disease unit, Tel Aviv Sourasky Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
³The Institute of Endocrinology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁴Department of ophthalmology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁵The Institute of Pulmonary Medicine, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁶Department of Oral Medicine, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁷Department of Dermatology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Tommy Alfaro, MD^1*, Anne Tierens, MD, PhD², Mariana Pinto Pereira, MD^3*, Arjun D. Law, MD^4*, Armin Gerbitz^4*, Auro Viswabandya⁴, Fotios V. Michelis^5*, Jeffrey H. Lipton⁴, Ivan Pasic^5*, Rajat Kumar⁴, Wilson Lam⁵, Jonas Mattsson^4*, Igor Novitzky-Basso, MD⁶ and Dennis D. H. Kim⁷

¹Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
²Laboratory Medicine Program, University Health Network, Toronto, ON, Canada
³Hans Messner Allogeneic Transplant Program, University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁴Hans Messner Allogenic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
⁵Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
⁶Hans Messner Allogeneic Blood and Marrow Transplant Unit, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁷Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network / Princess Margaret Cancer Centre, Toronto, ON, Canada

Betul Oran, MD, MS¹, Richard E Champlin, MD¹, Peter F Thall, PhD^2*, Jessica M McCarty^1*, Wen Zhang^3*, David Marin, MD¹, Rohtesh S. Mehta, MD¹, Amin M Alousi, MD¹, Gheath Alatrash, PhD, DO¹, Uday R Popat, MD¹, Hagop Kantarjian, MD⁴, Qaiser Bashir, MD¹, Elizabeth J Shpall, MD¹ and Marina Konopleva, MD, PhD⁵

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Biostatistics and Data Science, The University of Texas Health Science Center at Houston, Houston, TX
⁴Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Katja Sockel, MD^1*, Sandra Frank^2*, Annika Neu^3*, Markus Ditschkowski, PhD^4*, Inken Hilgendorf^5*, Mareen Goeckenjan^6*, Friedrich Stoelzel, MD³, Jan Moritz Middeke, MD^3*, Nicolaus Kröger, MD^7*, Francis A. Ayuk, MD^8*, Matthias Eder, MD^9*, Wolfgang Bethge, MD^10*, Jürgen Finke, MD, PhD¹¹, Hartmut Bertz, MD^12*, Guido Kobbe, MD^13*, Martin Kaufmann, MD¹⁴, Uwe Platzbecker, MD¹⁵, David Beverungen, MD^15*, Christoph Schmid, MD^16*, Malte von Bonin, MD^17*, Katharina Egger-Heidrich, MD^3*, Lisa Heberling^3*, Karolin Trautmann-Grill, MD^3*, Raphael Teipel, MD^3*, Gesine Bug, MD^18*, Johanna Tischer, MD^19*, Alessia Fraccaroli, MD^20*, Barbara Holler^21*, Daniel Wolff, MD^22*, Thomas Luft, MD, PhD²³, Wolf Roesler, M.D.^24*, Kerstin Schäfer-Eckart^25*, Sabine Dressler^26*, Christof Scheid²⁷, Udo Holtick, MD, PhD^28*, Stefan Klein, MD^29*, Igor Wolfgang Blau, MD^30*, Andreas Burchert, MD³¹, Gerald Wulf, MD^32*, Justin Hasenkamp^32*, Rainer Schwerdtfeger, MD^33*, Stephan Kaun, MD^34*, Christoph Wittke^35*, Friederike Wortmann^36*, Helga Neidlinger^37*, Martin Bornhaeuser, MD³, Johannes Schetelig, MD³ and on Behalf of the German Cooperative Transplant Study Group^38*

¹Medical Clinic and Policlinic I, University Hospital Dresden, TU Dresden, Dresden, Germany
²Institute of Statistics, University Ulm, Ulm, Germany
³Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany
⁴University Duisburg-Essen, Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
⁵Department of Internal Medicine II, University Clinic Jena, Jena University, Jena, Germany
⁶Department for Gynaecology and Obstetrics, University Hospital Dresden, Technical University Dresden,, Dresden, Germany
⁷University Medical Center Hamburg-Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany
⁸Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
⁹Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
¹⁰Department of Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany
¹¹Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
¹²Department of Hematology/Oncology/Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Germany
¹³Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
¹⁴2nd Department of Internal Medicine, Oncology and Hematology, Robert Bosch Hospital, Stuttgart, Germany
¹⁵Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital Leipzig, Leipzig, Germany
¹⁶Department of Haematology and Oncology, University Hospital and Medical Faculty Augsburg, Augsburg, Germany
¹⁷Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Saxony, Germany
¹⁸Goethe University Frankfurt, University Hospital, Dept. of Medicine, Hematology and Oncology, Frankfurt, Germany
¹⁹Dept of Internal Medicine III, LMU, University Hospital of Munich, Campus Großhadern,, Munich, Germany
²⁰Dept of Internal Medicine III, LMU, University Hospital of Munich, Campus Großhadern, Munich, Germany
²¹Medical Clinic III, University Medicine Regensburg, Regensburg, Germany
²²Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany
²³Department of Internal Medicine V (Hematology/Oncology/Rheumatology), Heidelberg University Hospital, Heidelberg, Germany
²⁴Department of Internal Medicine 5, University Hospital Erlangen, Erlangen, Germany
²⁵Department of Internal Medicine V, Nuremberg Hospital North, Paracelsus Medical University, Nuremberg, Germany
²⁶Department of Internal Medicine V, Nuremberg Hospital North, Paracelsus Medical University, Nuremberg, Bavaria, Germany
²⁷Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany
²⁸University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne, Germany
²⁹Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Germany
³⁰Department of BMT, Clinic of Hematology, Oncology and Tumorimmunology, University Medicine Berlin, Berlin, Germany
³¹Department of Hematology, Oncology and Immunology, Carreras Leukemia Center, Philips Univ. Marburg, Marburg, Hessen, Germany
³²University Medicine Göttingen, Hematology and Medical Oncology, Goettingen, Germany
³³Center for Hematopoietic Cell Transplantation, Deutsche Klinik für Diagnostik Helios Klinik, Wiesbaden, Germany
³⁴Hematology, Oncology und Infectiology, Clinic Bremen-Mitte, Bremen, Germany
³⁵Department of Medicine, Clinic III, Hematology, Oncology, Palliative Medicine, Rostock University Medical Center, Rostock, DEU
³⁶DDepartment of Hematology and Oncology, Medical Center, University of Schleswig-Holstein, Luebeck, Germany
³⁷German registry of stem cell transplantation (DRST), Ulm, Germany
³⁸German Cooperative Transplant Study Group, Dresden, Germany

Ali Alsugair, MBBS, Syed O. Ahmed, BSc, FRCPath, MBBS, MRCP^*, Mohamed Isam Sharif, MD^*, Tusneem Elhassan, MSc^*, Hazza A. Alzahrani, MD^*, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD, Fahad Alsharif, MD, DIM, MB ChB, Walid Rasheed, MB, ChB, FRACP, FRCPA, Amr Hanbali, MD^*, Feras Abdulaziz Alfraih, MD^*, Marwan Shaheen, MD^*, Riad El Fakih, MD^*, Saud Alhayli, MBBS^*, Ali Alahmari, MD^*, Alfadel Alshaibani, MD^*, Abdulwahab Albabtain, MD^*, Ahmad S. Alotaibi, MD^*, Mansour Alfayez, MD and Mahmoud Aljurf, MD

Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

Tamer Othman, MD^1,2*, Ibrahim Aldoss, MD³, Ni-Chun Tsai, MS^4*, Hoda Pourhassan, MD^3*, Vaibhav Agrawal, MD², Salman Otoukesh, MD^3*, Idoroenyi Amanam, MD³, Dat Ngo, PharmD^5*, Jason Chen, PharmD^5*, Monzr M. Al Malki, MD³, Amandeep Salhotra, MD³, Haris Ali, MD³, Ahmed Aribi, MD³, Karamjeet S. Sandhu, MD³, Shukaib Arslan, MD^3*, Brian J Ball, MD³, Forrest M. Stewart, MD^3*, Peter T. Curtin, MD³, Andrew S. Artz, MD, MS³, David S Snyder, MD², Guido Marcucci, MD³, Stephen J Forman, MD³, Anthony S. Stein, MD³, Ryotaro Nakamura, MD², Vinod A. Pullarkat, MD^3*, Matthew Mei, MD⁶ and Paul B. Koller, MD³

¹University of California Davis Comprehensive Cancer Center, Sacramento, CA
²Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
³Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁴Department of Computational and Quantitative Medicine-BRI, City of Hope National Medical Center, Duarte, CA
⁵Department of Pharmacy, City of Hope National Medical Center, Duarte, CA
⁶Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA

Maria Teresa Lupo-Stanghellini, MD^1*, Camilla Riva, MD^1*, Alessandro Bruno, MD^1*, Simona Piemontese, MD^1*, Raffaella Greco, MD^1*, Sarah Marktel, MD^1*, Sara Mastaglio, MD^1*, Elisabetta Xue, MD^1*, Daniela Clerici, MD^1*, Francesca Farina, MD^1*, Fabio Giglio, MD^1*, Elisa Diral, MD^1*, Luca Vago, MD, PhD^1,2, Consuelo Corti, MD^1*, Andrea A. Assanelli, MD^1*, Massimo Bernardi, MD^3*, Jacopo Peccatori, MD^1*, Matteo Giovanni Carrabba, MD^1* and Fabio Ciceri, MD^1,4*

¹Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milano, Italy
²Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano, Italy
³Hematology and Bone Marrow Transplantation Unit, +390817472241, Napoli, Italy
⁴Vita-Salute San Raffaele University, Milano, Italy